Alnylam Pharmaceuticals, Inc. (ALNY)
327.07
-5.78
(-1.74%)
USD |
NASDAQ |
Feb 25, 13:09
Alnylam Pharmaceuticals EPS Diluted from Accounting Change (Quarterly)
EPS Diluted from Accounting Change (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted from Accounting Change (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted from Accounting Change (Quarterly) Benchmarks
| Insmed, Inc. | -- |
| Biogen, Inc. | -- |
| Pfizer Inc. | -- |
| Eli Lilly & Co. | -- |
| AbbVie, Inc. | -- |